Pharma Ex-Exec Can't Revive $12M Underpayment Suit in US
By Jonathan Capriel · April 18, 2024, 7:32 PM EDT
A Manhattan federal judge has refused to rethink her decision tossing a $12 million suit accusing Altum Pharmaceuticals Inc. and its cannabis-focused parent company, BetterLife Pharma Inc., of stock dilution and...
To view the full article, register now.